DMII · Drugs Made In America Acquisition II Corp.
$10.11
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$644.01M
Shares
63.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 10-K | 2026-04-15 | 2025-12-31 | |
| 8-K | 2026-04-03 | 2026-03-24 | |
| 8-K | 2026-03-17 | 2026-03-11 | |
| 8-K | 2026-03-06 | 2026-02-28 | |
| 8-K | 2026-03-06 | — | |
| 10-Q | 2025-11-18 | 2025-09-30 | |
| 8-K | 2025-11-18 | 2025-10-08 | |
| 8-K | 2025-10-02 | 2025-09-26 | |
| 8-K | 2025-09-29 | 2025-09-24 |
Showing 1–11 of 11 filings
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
8 filings
8 filers